Skip NavigationSkip to Content

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development

  1. Author:
    Smith, J. L.
    Bu, W.
    Burdick, R. C.
    Pathak, V. K.
  2. Author Address

    [Smith, Jessica L.; Bu, Wei; Burdick, Ryan C.; Pathak, Vinay K.] NCI, Viral Mutat Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA. [Bu, Wei] SAIC Frederick, Frederick, MD 21702 USA.;Pathak, VK, NCI, Viral Mutat Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA.;vinay.pathak@nih.gov
    1. Year: 2009
    2. Date: Dec
  1. Journal: Trends in Pharmacological Sciences
    1. 30
    2. 12
    3. Pages: 638-646
  2. Type of Article: Review
  3. ISSN: 0165-6147
  1. Abstract:

    HIV-1 infections and the resulting AIDS pandemic remain a global challenge in the absence of a protective vaccine and because of rapid selection of drug-resistant viral variants in response to all currently available antiviral therapies. The development of new and highly active antiviral agents would greatly facilitate effective clinical management of HIV-1 infections and delay the onset of AIDS. Recent advances in our understanding of intracellular immunity conferred by host cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) and the mechanism by which the virally encoded virion infectivity factor (Vif) protein induces their proteasomal degradation provide fresh opportunities for the development of novel antiviral treatments. Interestingly, the Vif-A3G and Vif-A3F interactions that overcome this host defense mechanism are structurally distinct and provide two potential targets for antiviral drug development. This review provides an overview of current knowledge of APOBEC3-Vif interactions and recent efforts to target these interactions for antiviral drug development.

    See More

External Sources

  1. DOI: 10.1016/j.tips.2009.09.006
  2. WOS: 000273221200006

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel